E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

Medicine and Dentistry

• Krukenberg Tumor 100%
• CA-125 60%
• Western Blot 60%
• Cancer 40%
• Tissues 30%
• Diseases 20%
• Serum 20%
• Transcription Factor 20%
• Cancer Diagnosis 20%
• Transcription Factor E2F5 20%
• Cyst 20%
• Diagnosis 20%
• Gene 20%
• Marker 20%
• Accuracy 20%
• Cell Cycle Protein 20%
• Ovarian Cancer 10%
• Pathogenesis 10%
• Tissue Microarray 10%
• Tumor Marker 10%
• Cell Cycle 10%
• Tumor Progression 10%
• Cell Proliferation 10%
• Analysis 10%
• Patient 10%

Biochemistry, Genetics and Molecular Biology

• E2F5 70%
• CA-125 60%
• Sample 30%
• Nested Gene 20%
• Transcription Factor 20%
• Transcription Factor E2F5 20%
• Accuracy 20%
• Tissue Microarray 10%
• Tumor Progression 10%
• Cell Cycle 10%
• Cell Proliferation 10%
• Experiment 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Ovary Carcinoma 100%
• Diseases 20%
• Transcription Factor 20%
• Cyst 20%
• Transcription Factor E2F5 20%
• Pathogenesis 10%
• Tumor Growth 10%
• Ovary Cancer 10%